A phase-2 clinical study to determine the efficacy and safety of DepoCyte (cytarabine liposome injection) for the treatment of CNS relapse in adult patients with acute lymphoblastic leukemia or very aggressive lymphoma
Latest Information Update: 22 Aug 2022
At a glance
- Drugs Cytarabine (Primary) ; Dexamethasone (Primary)
- Indications Non-Hodgkin's lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 16 Aug 2022 Status changed from active, no longer recruiting to completed.
- 22 Oct 2005 New trial record.